日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Incidence and management of pyrexia syndrome in patients treated with dabrafenib and trametinib: a retrospective study

达拉非尼和曲美替尼治疗患者发热综合征的发生率及处理:一项回顾性研究

Komisarof, Justin; Menon, Jayesh; Andrzejewski, Aryn; Mulford, Deborah

Lower, more frequent cisplatin dosing minimizes hearing loss in head and neck cancer

降低顺铂给药剂量并增加给药频率可最大程度地减少头颈癌患者的听力损失。

Fernandez, Katharine A; Chowdhury, Abu S; Bonczkowski, Amanda; Allen, Paul D; Campbell, Maura H; Lee, David S; Malhotra, Charvi; Page, Brandi R; Mulford, Deborah A; Ortiz, Candice Evita; Santa Maria, Peter L; Kullar, Peter; Khan, Saad A; Newlands, Shawn D; Schmitt, Nicole C; Cunningham, Lisa L

Long-Term Management of Brain Metastases From Small-Cell Lung Cancer: A Case Report of a Survivor Treated With Multiple Stereotactic Radiosurgeries

小细胞肺癌脑转移的长期管理:一例接受多次立体定向放射外科治疗的幸存者病例报告

Milano, Michael T; Mulford, Deborah A; Prasad, Dheerendra; Almeida, Neil; Usuki, Kenneth

Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia

针对复发/难治性慢性淋巴细胞白血病的响应适应性、限时维奈托克、乌布拉利西布和乌布妥昔单抗治疗

Hill, Brian T; Ma, Shuo; Zent, Clive S; Baran, Andrea M; Wallace, Danielle S; Advani, Anjali; Winter, Allison; Winter, Jane; Gordan, Leo; Karmali, Reem; Liesveld, Jane L; Mulford, Deborah A; Rowland, Chris; Bui, Andrew; Sportelli, Peter; Miskin, Hari P; Weiss, Michael S; Friedberg, Jonathan W; Barr, Paul M

Patient-reported impact of symptoms in lung cancer (PRISM-LC)

肺癌症状患者报告影响(PRISM-LC)

Varma, Anika; Weinstein, Jennifer; Seabury, Jamison; Rosero, Spencer; Zizzi, Christine; Dilek, Nuran; Heatwole, John; Baumgart, Megan; Mulford, Deborah; Maggiore, Ronald; Conrow, Lainie; King, Jennifer C; Wiens, Jacinta; Heatwole, Chad

Risk of brain metastases in T1-3N0 NSCLC: a population-based analysis

T1-3N0期非小细胞肺癌脑转移风险:一项基于人群的分析

Milano, Michael T; Bates, James E; Budnik, Justin; Qiu, Haoming; Hardy, Sara; Cummings, Michael A; Baumgart, Megan A; Maggiore, Ronald J; Mulford, Deborah A; Usuki, Kenneth Y

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2

在服务不足的患者群体中开展基于纳米白蛋白紫杉醇的治疗:ABOUND.PS2 研究,纳入体能状态评分为 2 的非小细胞肺癌患者。

Gajra, Ajeet; Karim, Nagla Abdel; Mulford, Deborah A; Villaruz, Liza Cosca; Matrana, Marc Ryan; Ali, Haythem Y; Santos, Edgardo S; Berry, Tymara; Ong, Teng Jin; Sanford, Alexandra; Amiri, Katayoun; Spigel, David R

SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia

SWOG0919:一项伊达比星和阿糖胞苷联合普伐他汀治疗复发性急性髓系白血病的 II 期研究

Advani, Anjali S; McDonough, Shannon; Copelan, Edward; Willman, Cheryl; Mulford, Deborah A; List, Alan F; Sekeres, Mikkael A; Othus, Megan; Appelbaum, Frederick R

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)

伊扎替司他盐酸盐联合来那度胺治疗非缺失(5q)低危至中危-1 骨髓增生异常综合征(MDS)患者的 1 期剂量范围研究

Raza, Azra; Galili, Naomi; Mulford, Deborah; Smith, Scott E; Brown, Gail L; Steensma, David P; Lyons, Roger M; Boccia, Ralph; Sekeres, Mikkael A; Garcia-Manero, Guillermo; Mesa, Ruben A

Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell lines.

蛋白酶体抑制在骨髓增生异常综合征和急性髓系白血病细胞系中的作用

Liesveld Jane L, Rosell Karen E, Bechelli Jeremy, Lu Chaohui, Messina Patti, Mulford Deborah, Ifthikharuddin J J, Jordan Craig T, Phillips Ii Gordon L